A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

NCT02698852 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-04-25

No results posted yet for this study

Summary

PIONEER-II OPC trial is a prospective, multicenter, single-arm registry trial. 1000 subjects from approximately 40 interventional cardiology centers will be enrolled to evaluate the target lesion failure(TLF) as the primary endpoint at 1 year. And all the subjects will be followed up to 5 years to attain the data of the secondary endpoints.

Conditions

Interventions

DEVICE

BuMA Supreme

Stent platform: cobalt-chromium alloy

Sponsors & Collaborators

  • Sino Medical Sciences Technology Inc.

    lead INDUSTRY

Principal Investigators

  • Junbo Ge, M.D. · Shanghai Zhongshan Hospital

  • Shubin Qiao, M.D. · Chinese Academy of Medical Sciences, Fuwai Hospital

  • Yundai Chen, M.D. · Chinese PLA General Hospital

  • Shaoping Nie, M.D. · Beijing Anzhen Hospital

  • Yawei Xu, M.D. · Shanghai 10th People's Hospital

  • Xiangqing Kong, M.D. · Jiangsu Proving Hospital

  • Lang Li, M.D. · First Affiliated Hospital of Guangxi Medical University

  • Xiangqian Shen, M.D. · Central South University

  • Hui Li, M.D. · Daqing oilfield general hospital

  • Linghong Shen, M.D. · Shanghai Chest Hospital

  • Xi Su, M.D. · Wuhan Asia Heart Hospital

  • Jiyan Chen, M.D. · Guangdong Provincial People's Hospital

  • Genshang Ma, M.D. · Zhongda Hospital

  • Xiaoshu Cheng, M.D. · Second Affiliated Hospital of Nanchang University

  • Guosheng Fu, M.D. · Run Run Shaw Hospital

  • Zesheng Xu, M.D. · Cangzhou Central Hospital

  • Bin Li, M.D. · Hainan General Hospital

  • Jianan Wang, M.D. · The Second Affiliated Hospital of Zhejiang University School of Medical College

  • Haichu Yu, M.D. · The Affiliated Hospital of Qingdao University

  • Guotai Shen, M.D. · Jiangxi Provincial People's Hopital

  • Xiandong Li, M.D. · Shengjing Hospital

  • Xianxian Zhao, M.D. · Changhai Hospital

  • Tingbo Jiang, M.D. · The First Affiliated Hospital of Soochow University

  • Mingzhe Li, M.D. · Xuzhou Central Hospital

  • Zheng Zhang, M.D. · LanZhou University

  • Bei Shi, M.D. · Zunyi Medical College

  • Jinyu Huang, M.D. · Affiliated Hangzhou First People's Hospital ,Zhengzhou University School of Medicine

  • Honghua Ye, M.D. · Hua Mei Hospital, University of Chinese Academy of Sciences(Ningbo No.2 Hospital)

  • Guohai Su, M.D. · Jinan Central Hospital

  • Hanjun Pei, M.D. · The First Affiliated Hospital of BaoTou Medical College

  • Shaobin Jia, M.D. · General Hospital of Ningxia Medical University

  • Chun Liang, M.D. · Shanghai Changzheng Hospital

  • Ronghai Man, M.D. · Chifeng Municipal Hospital

  • Jinchuan Yan, M.D. · Affiliated Hospital of Jiangsu University

  • Xuchen Zhou, M.D. · The First Affiliated Hospital of Dalian Medical University

  • Zhenyu Yang, M.D. · Wuxi People's Hospital

  • Yuehui Yin, M.D. · The Second Affiliated Hospital of Chongqing Medical University

  • Chunlai Zeng, M.D. · The Central Hospital of Lishui City

  • Kejun Huang, M.D. · Henan Provincial Chest Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2019-05-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698852 on ClinicalTrials.gov